Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 1
2004 1
2006 1
2008 1
2009 2
2010 2
2011 3
2012 4
2013 8
2014 16
2015 16
2016 21
2017 22
2018 28
2019 25
2020 6
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 29748614

141 results
Results by year
Filters applied: . Clear all
Page 1
Effect of PEG-PDLLA polymeric nanovesicles loaded with doxorubicin and hematoporphyrin monomethyl ether on human hepatocellular carcinoma HepG2 cells in vitro.
Xiang GH, Hong GB, Wang Y, Cheng D, Zhou JX, Shuai XT. Xiang GH, et al. Int J Nanomedicine. 2013;8:4613-22. doi: 10.2147/IJN.S54142. Epub 2013 Dec 2. Int J Nanomedicine. 2013. PMID: 24324333 Free PMC article.
Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer.
Chang JE, Yoon IS, Sun PL, Yi E, Jheon S, Shim CK. Chang JE, et al. J Photochem Photobiol B. 2014 Nov;140:49-56. doi: 10.1016/j.jphotobiol.2014.07.005. Epub 2014 Jul 24. J Photochem Photobiol B. 2014. PMID: 25090224
Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
Ding Y, Han J, Tian B, Han J, Zhang J, Zheng H, Han Y, Pei M. Ding Y, et al. Int J Pharm. 2014 Dec 30;477(1-2):187-96. doi: 10.1016/j.ijpharm.2014.10.024. Epub 2014 Oct 16. Int J Pharm. 2014. PMID: 25455771
Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y, Lu Y, Wang L, Lu W, Huang J, Muir B, Yu J. Xu Y, et al. Colloids Surf B Biointerfaces. 2016 May 1;141:318-326. doi: 10.1016/j.colsurfb.2016.01.044. Epub 2016 Jan 28. Colloids Surf B Biointerfaces. 2016. PMID: 26874117
Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib.
Duan W, Liu Y. Duan W, et al. Drug Des Devel Ther. 2018 Jul 11;12:2149-2161. doi: 10.2147/DDDT.S166402. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30034219 Free PMC article.
Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X, Chen Q, Li Y, Tang H, Liu W, Yang X. Zhao X, et al. Eur J Pharm Biopharm. 2015 Jun;93:27-36. doi: 10.1016/j.ejpb.2015.03.003. Epub 2015 Mar 11. Eur J Pharm Biopharm. 2015. PMID: 25770771
Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects.
Gao F, Li L, Liu T, Hao N, Liu H, Tan L, Li H, Huang X, Peng B, Yan C, Yang L, Wu X, Chen D, Tang F. Gao F, et al. Nanoscale. 2012 Jun 7;4(11):3365-72. doi: 10.1039/c2nr12094a. Epub 2012 Apr 27. Nanoscale. 2012. PMID: 22538830
141 results
Jump to page
Feedback